Literature DB >> 26965440

Age, not therapy intensity, determines outcomes of adults with acute myeloid leukemia.

T Büchner1, U O Krug2, R Peter Gale3, A Heinecke4, M C Sauerland4, C Haferlach5, S Schnittger5, T Haferlach5, C Müller-Tidow1, M Stelljes1, R M Mesters1, H L Serve6, J Braess7, K Spiekermann8, P Staib9, A Grüneisen10, A Reichle11, L Balleisen12, H Eimermacher13, A Giagounidis14, H Rasche15, E Lengfelder16, D Görlich4, A Faldum4, W Köpcke4, R Hehlmann16, B J Wörmann17, W E Berdel1, W Hiddemann8.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 26965440     DOI: 10.1038/leu.2016.54

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  14 in total

1.  Priming with granulocyte colony-stimulating factor--relation to high-dose cytarabine in acute myeloid leukemia.

Authors:  Thomas Büchner; Wolfgang E Berdel; Wolfgang Hiddemann
Journal:  N Engl J Med       Date:  2004-05-20       Impact factor: 91.245

2.  SAS macros for estimation of the cumulative incidence functions based on a Cox regression model for competing risks survival data.

Authors:  Susanne Rosthøj; Per K Andersen; Steen Z Abildstrom
Journal:  Comput Methods Programs Biomed       Date:  2004-04       Impact factor: 5.428

3.  Age and acute myeloid leukemia.

Authors:  Frederick R Appelbaum; Holly Gundacker; David R Head; Marilyn L Slovak; Cheryl L Willman; John E Godwin; Jeanne E Anderson; Stephen H Petersdorf
Journal:  Blood       Date:  2006-02-02       Impact factor: 22.113

4.  Internal tandem duplication of the flt3 gene found in acute myeloid leukemia.

Authors:  M Nakao; S Yokota; T Iwai; H Kaneko; S Horiike; K Kashima; Y Sonoda; T Fujimoto; S Misawa
Journal:  Leukemia       Date:  1996-12       Impact factor: 11.528

Review 5.  Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.

Authors:  Hartmut Döhner; Elihu H Estey; Sergio Amadori; Frederick R Appelbaum; Thomas Büchner; Alan K Burnett; Hervé Dombret; Pierre Fenaux; David Grimwade; Richard A Larson; Francesco Lo-Coco; Tomoki Naoe; Dietger Niederwieser; Gert J Ossenkoppele; Miguel A Sanz; Jorge Sierra; Martin S Tallman; Bob Löwenberg; Clara D Bloomfield
Journal:  Blood       Date:  2009-10-30       Impact factor: 22.113

6.  Allogeneic transplantation versus chemotherapy as postremission therapy for acute myeloid leukemia: a prospective matched pairs analysis.

Authors:  Matthias Stelljes; Utz Krug; Dietrich W Beelen; Jan Braess; Maria C Sauerland; Achim Heinecke; Sandra Ligges; Tim Sauer; Petra Tschanter; Gabriela B Thoennissen; Björna Berning; Hans J Kolb; Albrecht Reichle; Ernst Holler; Rainer Schwerdtfeger; Renate Arnold; Christoph Scheid; Carsten Müller-Tidow; Bernhard J Woermann; Wolfgang Hiddemann; Wolfgang E Berdel; Thomas Büchner
Journal:  J Clin Oncol       Date:  2013-12-23       Impact factor: 44.544

7.  Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia.

Authors:  Krzysztof Mrózek; Guido Marcucci; Deedra Nicolet; Kati S Maharry; Heiko Becker; Susan P Whitman; Klaus H Metzeler; Sebastian Schwind; Yue-Zhong Wu; Jessica Kohlschmidt; Mark J Pettenati; Nyla A Heerema; AnneMarie W Block; Shivanand R Patil; Maria R Baer; Jonathan E Kolitz; Joseph O Moore; Andrew J Carroll; Richard M Stone; Richard A Larson; Clara D Bloomfield
Journal:  J Clin Oncol       Date:  2012-09-17       Impact factor: 44.544

8.  Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trials.

Authors:  Keith Wheatley; Cassandra L Brookes; Andrew J Howman; Anthony H Goldstone; Donald W Milligan; Archibald G Prentice; Anthony V Moorman; Alan K Burnett
Journal:  Br J Haematol       Date:  2009-03-26       Impact factor: 6.998

9.  High remission-induction rate in acute myeloid leukaemia.

Authors:  R P Gale; M J Cline
Journal:  Lancet       Date:  1977-03-05       Impact factor: 79.321

10.  Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B.

Authors:  R J Mayer; R B Davis; C A Schiffer; D T Berg; B L Powell; P Schulman; G A Omura; J O Moore; O R McIntyre; E Frei
Journal:  N Engl J Med       Date:  1994-10-06       Impact factor: 91.245

View more
  8 in total

1.  How good are we at predicting the fate of someone with acute myeloid leukaemia?

Authors:  E Estey; R P Gale
Journal:  Leukemia       Date:  2017-03-17       Impact factor: 11.528

2.  Commentary on: 'Age, not therapy intensity, determines outcomes of adults with acute myeloid leukemia'.

Authors:  C A Schiffer
Journal:  Leukemia       Date:  2016-06-10       Impact factor: 11.528

3.  Randomized study of continuous high-dose lenalidomide, sequential azacitidine and lenalidomide, or azacitidine in persons 65 years and over with newly-diagnosed acute myeloid leukemia.

Authors:  Bruno C Medeiros; Kelly McCaul; Suman Kambhampati; Daniel A Pollyea; Rajat Kumar; Lewis R Silverman; Andrea Kew; Lalit Saini; C L Beach; Ravi Vij; Xiwei Wang; Jim Zhong; Robert Peter Gale
Journal:  Haematologica       Date:  2017-11-02       Impact factor: 9.941

4.  Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1/RUNX1T1 fusions influencing survival of patients with acute myeloid leukemia.

Authors:  Roman Hornung; Vindi Jurinovic; Aarif M N Batcha; Stefanos A Bamopoulos; Maja Rothenberg-Thurley; Susanne Amler; Maria Cristina Sauerland; Wolfgang E Berdel; Bernhard J Wörmann; Stefan K Bohlander; Jan Braess; Wolfgang Hiddemann; Sören Lehmann; Sylvain Mareschal; Karsten Spiekermann; Klaus H Metzeler; Tobias Herold; Anne-Laure Boulesteix
Journal:  Sci Rep       Date:  2018-07-26       Impact factor: 4.379

5.  Can the Gene Expression Profile of Patients with Acute Myeloid Leukemia Predict Complete Remission Following Induction Therapy?

Authors:  Santiago Sánchez-Sosa; Carlos Rodríguez-Medina; Ruth Stuckey; Yanira Florido; Guillermo Santana; Jesús María González Martín; Naylén Cruz-Cruz; Melissa Torres-Ochando; Rosa Fernández; Nuria Sánchez-Farías; Antonia Cionfrini; Teresa Molero Labarta; María Teresa Gomez-Casares; Cristina Bilbao-Sieyro
Journal:  J Cancer       Date:  2022-02-14       Impact factor: 4.207

6.  A 29-gene and cytogenetic score for the prediction of resistance to induction treatment in acute myeloid leukemia.

Authors:  Tobias Herold; Vindi Jurinovic; Aarif M N Batcha; Stefanos A Bamopoulos; Maja Rothenberg-Thurley; Bianka Ksienzyk; Luise Hartmann; Philipp A Greif; Julia Phillippou-Massier; Stefan Krebs; Helmut Blum; Susanne Amler; Stephanie Schneider; Nikola Konstandin; Maria Cristina Sauerland; Dennis Görlich; Wolfgang E Berdel; Bernhard J Wörmann; Johanna Tischer; Marion Subklewe; Stefan K Bohlander; Jan Braess; Wolfgang Hiddemann; Klaus H Metzeler; Ulrich Mansmann; Karsten Spiekermann
Journal:  Haematologica       Date:  2017-12-14       Impact factor: 9.941

7.  Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia-a phase 3 study.

Authors:  Jan Braess; Susanne Amler; Karl-Anton Kreuzer; Karsten Spiekermann; Hans Walter Lindemann; Eva Lengfelder; Ullrich Graeven; Peter Staib; Wolf-Dieter Ludwig; Harald Biersack; Yon-Dschun Ko; Michael J Uppenkamp; Maike De Wit; Stefan Korsten; Rudolf Peceny; Tobias Gaska; Xaver Schiel; Dirk M Behringer; Michael G Kiehl; Bettina Zinngrebe; Gerald Meckenstock; Eva Roemer; Dirk Medgenberg; Ernst Spaeth-Schwalbe; Gero Massenkeil; Heidrun Hindahl; Rainer Schwerdtfeger; Guido Trenn; Cristina Sauerland; Raphael Koch; Martin Lablans; Andreas Faldum; Dennis Görlich; Stefan K Bohlander; Stephanie Schneider; Annika Dufour; Christian Buske; Michael Fiegl; Marion Subklewe; Birgit Braess; Michael Unterhalt; Anja Baumgartner; Bernhard Wörmann; Dietrich Beelen; Wolfgang Hiddemann
Journal:  Leukemia       Date:  2018-10-01       Impact factor: 11.528

8.  Priority-Lasso: a simple hierarchical approach to the prediction of clinical outcome using multi-omics data.

Authors:  Simon Klau; Vindi Jurinovic; Roman Hornung; Tobias Herold; Anne-Laure Boulesteix
Journal:  BMC Bioinformatics       Date:  2018-09-12       Impact factor: 3.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.